POSTER: MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Primary Analysis Results From the MCL Cohort of the Single-Arm, Multicenter, Phase I Seamless Design TRANSCEND NHL 001 Study
Year: 2023
Type: article
Authors: M. Lia Palomba, Tanya Siddiqi, Leo I. Gordon, Manali Kamdar, Matthew Lunning, Alexandre V. Hirayama, Jeremy S. Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Charalambos Andreadis, Scott R. Solomon, Ana Kostic, Christine Dehner, Ricardo Espinola, Lily Peng, Ken Ogasawara, Amy Chattin, Michael Wang
Institutions: Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Colorado Cancer Center, University of Nebraska Medical Center, Fred Hutch Cancer Center, Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Levine Cancer Institute, University of Alabama at Birmingham, University of California, San Francisco, Northside Hospital, Bristol-Myers Squibb (United States), The University of Texas MD Anderson Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4386282047